MRK vs ELV
By Alex · Tickerpine
Merck & Co., Inc. vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ELV |
|---|---|---|
| Price | $147.76 | $429.69 |
| Market cap | $364.26B | $92.84B |
| P/E ratio | 149.3 | 18.2 |
| ROE | 5.06% | 11.48% |
| Profit margin | 3.64% | 2.55% |
| Revenue growth | 4.70% | 1.40% |
| Dividend yield | 2.30% | 1.60% |
| Beta | 0.12 | 0.63 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ELV in plain English
- MRK is the bigger company — about 3.9× the market cap of ELV.
- ELV is cheaper on earnings (P/E 18.2 vs 149.3).
- ELV earns a higher return on equity (11% vs 5%).
- MRK is growing revenue faster (5% vs 1%).
- MRK has the higher dividend yield (2.30% vs 1.60%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.